National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

oral picoplatin
An oral preparation of picoplatin, a third generation platinum compound with antineoplastic activity. Designed to overcome platinum drug resistance, picoplatin alkylates DNA, forming both inter- and intra-strand cross-linkages, resulting in inhibition of DNA replication and RNA transcription and the induction of apoptosis. Because of the increase in steric bulk around the platinum center, there is a relative reduction in the inactivation of picoplatin by thiol-containing species such as glutathione and metallothionein in comparison to cisplatin. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)




Previous:oral Hsp90 inhibitor IPI-493, oral JAK inhibitor INCB18424, oral JAK2 inhibitor SB1518, oral microencapsulated diindolylmethane, oral milataxel
Next:oral sodium phenylbutyrate, oral topotecan hydrochloride, Oralet, Oramorph, Oramorph SR

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov